Brain insulin study targets antipsychotic side effects in women

NCT ID NCT06251635

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This study looks at how antipsychotic drugs might cause metabolic problems in women by affecting how the brain responds to insulin. Researchers will give 15 healthy women a single dose of the antipsychotic olanzapine and insulin nasal spray, then use brain scans to see changes. The goal is to understand why women on these drugs have higher rates of diabetes and weight gain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANTIPSYCHOTICS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Centre for Addiction and Mental Health (CAMH)

    RECRUITING

    Toronto, Ontario, M6J 1H3, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.